Optimization of biotinylation protocol for next generation studies of red blood cell survival after transfusion
RBC biotinylation 48 h prior to transfusion does not compromise the quality and safety of BioRBC products. BioRBC long-term survival can be used to identify donor characteristics that influence RBC lifespan in the circulation.
Authors
- Dylan Bowen (ORCID: https://orcid.org/0009-0007-5905-5531)
- Gemlyn George (ORCID: https://orcid.org/0000-0002-4518-0629)
- Tamir Kanias (ORCID: https://orcid.org/0000-0001-6558-0913)
- Jeffrey M. Finlon
- Kathleen Kelly (ORCID: https://orcid.org/0000-0002-1102-6279)
- Philip J. Norris (ORCID: https://orcid.org/0000-0003-0526-2088)
- Susanne Marschner (ORCID: https://orcid.org/0000-0002-7862-6201)
- Crystal Stanley
- Michelle Barton (ORCID: https://orcid.org/0000-0001-7707-8154)
- M.A. Rahman (ORCID: https://orcid.org/0000-0002-0468-2518)
- Mary Berg (ORCID: https://orcid.org/0000-0002-4961-245X)
- Deborah Lee
- Joseph Sekiya
- Timothy Gehris
Institutions
- University of California, San Francisco (US)
- Pacific Research Institute (US)
- Vitalant (US)
- University of Colorado Anschutz Medical Campus (US)
Publication Details
- Journal
- Transfusion
- Published
- 2025-05-20
- DOI
- https://doi.org/10.1111/trf.18286
- Citations
- 2
- Primary Topic
- Erythrocyte Function and Pathophysiology
- Type
- article
- Field-Weighted Citation Impact
- 2.33
Funders
- National Heart, Lung, and Blood Institute